A qPCR kit and method for simultaneously detecting two mutation sites on a single target gene.

By designing a multiplex PCR amplification method using specific primers and high Tm value Tag sequence primers, combined with molecular beacon hybridization technology, the sensitivity and specificity issues of SLC10A1 gene mutation site detection under low DNA concentrations were solved, achieving efficient and accurate genotype analysis.

CN116970685BActive Publication Date: 2026-11-10GUANGDONG WOMEN & CHILDREN HOSPITAL
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202310230859.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-11
Publication Date
2026-11-10
Estimated Expiration
2043-03-11

AI Technical Summary

Technical Problem

Existing technologies struggle to detect the two mutation sites c.800C>T and c.263T>C of the SLC10A1 gene with high sensitivity and specificity under low DNA concentration conditions, especially in neonatal dried blood smear samples where nonspecific amplification and erroneous detection results are prone to occur.

Method used

By designing specific primers and molecular beacons and using Tag sequence primers with high Tm values, PCR single-stranded products of two mutation sites can be prepared simultaneously in one tube through multiplex PCR amplification and molecular beacon hybridization. Combined with Tag sequence primers and molecular beacon probes with high Tm values, high sensitivity and specificity detection can be achieved.

Benefits of technology

This study achieved highly sensitive and specific detection of two mutation sites in the SLC10A1 gene under low DNA concentration conditions, improving the accuracy and reliability of detection and avoiding misinterpretation caused by nonspecific amplification.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116970685B_ABST
    Figure CN116970685B_ABST
Patent Text Reader

Abstract

This invention provides a qPCR kit and method for simultaneously detecting two mutation sites on a target gene. The kit includes forward and reverse primers for amplifying each mutation site, two Tag sequence primers for single-primer amplification of each mutation site, wherein the Tag sequence primers are formed by adding a Tag sequence to one end of the forward or reverse primer; and wild-type and mutant molecular beacons for each mutation site. This invention designs specific primers and molecular beacons for two mutation sites of a gene, and prepares single-stranded target-molecular hybridization by combining conventional primers with high-Tm primers containing tags. This achieves efficient detection of the genotype of the mutation site with good sensitivity and specificity, thus solving the problem of low detection sensitivity in dried blood smear samples from newborns.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of molecular biology, and in particular to a qPCR kit and method for simultaneously detecting two mutation sites on a target gene. Background Technology

[0002] Mutations in the SLC10A1 gene can lead to sodium taurocholic acid cotransporter polypeptide (NTCP) deficiency, a hereditary bile acid metabolism disorder. To date, 10 SLC10A1 gene mutation sites have been reported in China, with the two most frequent sites being c.800C>T and c.263T>C, exhibiting high mutation frequencies in populations in my country and Southeast Asia. This invention uses SLC10A1 gene mutations as an example to describe a novel kit and method for detecting two mutation sites in a single gene. Summary of the Invention

[0003] This invention provides a qPCR kit for simultaneously detecting two mutation sites on a target gene. The kit comprises: a forward primer and a reverse primer for amplifying each mutation site; two Tag sequence primers, each used for single-primer amplification of one mutation site, wherein the Tag sequence primers are formed by adding a Tag sequence to one end of either the forward or reverse primer; the two Tag sequence primers contain the same Tag sequence; single-primer amplification of each mutation site uses its own Tag sequence primer; during amplification detection, PCR products for both mutation sites are simultaneously prepared into single strands in one tube; a wild-type molecular beacon and a mutant molecular beacon for each mutation site; and when the molecular beacon probe for one mutation site is designed on the positive strand, the Tag sequence of that mutation site is added to one end of the reverse primer to obtain a Tag sequence primer for that sequence; when the molecular beacon probe for one mutation site is designed on the negative strand, the Tag sequence of that mutation site is added to one end of the forward primer to obtain a Tag sequence primer for that sequence.

[0004] In one embodiment, the Tm values ​​of the forward primer and the reverse primer are between 50 and 56°C, and the Tm value of the Tag sequence primer is not lower than 65°C.

[0005] In one embodiment, the kit is a kit for detecting c.800C>T and c.263T>C at two sites of the SLC10A1 gene.

[0006] In one embodiment, the forward primer SEQ ID NO:1: CATGGAGACTGGATGC, the reverse primer SEQ ID NO:2: AGAGAAAAGTGGTCCAA, and the Tag sequence primer SEQ ID NO:3: gccatgtcgcgttgctggtgaAGAAGAAAAGTGGTCCAA are used for amplifying c.800C>T; the wild-type molecular beacon SEQ ID NO:4: FAM-gtcacCCAACTCTGTTCCACCATCCTCAgtgac-Dabcyl and the mutant molecular beacon SEQ ID NO:5: VIC-gtcacTCCAACTCTGTTTCACCATCCTCAAgtgac-BHQ1 are used for amplifying c.263T>C; the forward primer SEQ ID NO:6: GCTCACTTATGGAAGCCTA, the reverse primer SEQ ID NO:7: CAGCCACAGACCAAGATG, and the Tag sequence primer SEQ ID NO:4 are used for amplifying c.800C>T. ID NO:8: gccatgtcgcgttgctggtgaAGAAGAAAAGTGGTCCAA; Wild-type molecular beacon SEQ ID NO:9: gccatgtcgcgttgctggtgaGCTCACTTATGGAAGCCTA; and mutant molecular beacon SEQ ID NO:10: Cy5-cgtcacaCCAGTGCCTCAGTGTTCTTCAGCCtgtgacg-BHQ2.

[0007] In one embodiment, a qPCR amplification method is provided that simultaneously detects two mutation sites on a target gene using the above-described kit.

[0008] In one embodiment, the method includes first performing PCR amplification using the forward primer and the reverse primer, and then raising the annealing temperature above the Tm value of the Tag sequence primer, at which point only the Tag sequence primer can bind to the template DNA, thereby causing single-primer amplification.

[0009] In one embodiment, the method uses the qPCR kit of claim 4, and the qPCR reaction conditions are 50°C for 3 minutes, 95°C for 10 minutes, 94°C for 30 seconds, 52°C for 60 seconds, and 72°C for 30 seconds for the first 20 cycles; and 94°C for 30 seconds, 65°C for 60 seconds, 72°C for 30 seconds, and 72°C for 5 minutes for the next 25 cycles.

[0010] This invention designs specific primers and molecular beacons targeting two mutation sites in a single gene. It prepares single-stranded targets by combining conventional primers with high-Tm primers containing tags, and hybridizes these targets with the molecular beacons. This method efficiently detects the genotype of the mutation sites with good sensitivity and specificity, addressing the issue of low detection sensitivity in neonatal dried blood smear samples. The detection kit provided by this invention is sensitive and can rapidly and accurately detect two gene mutation sites in human-derived samples. Attached Figure Description

[0011] To more clearly illustrate the technical solutions in the embodiments of this application, the accompanying drawings used in the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments recorded in this application. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0012] Figure 1 The image shows the detection results of the qPCR system using Tag1 sequence primers for the genotype TT at the 263 site of the SLC10A1 gene in specimen No. 6 of this invention.

[0013] Figure 2 The image shows the detection results of the genotype TT at position 263 of the SLC10A1 gene in specimen No. 6 of this invention, detected using a standard qPCR system without the tag sequence.

[0014] Figure 3 The image shows the detection results of the SLC10A1 gene at locus 263 of specimen No. 6 of this invention, which has a genotype of TT, detected using a qPCR system with the Tag2 sequence added.

[0015] Figure 4 The image shows the detection results of the qPCR system using Tag1 sequence primers, with the genotype CT at position 800 of the SLC10A1 gene in specimen number 2.

[0016] Figure 5 The image shows the detection result of the genotype CT at position 800 of the SLC10A1 gene in specimen number 2, obtained using a standard qPCR system without the tag sequence.

[0017] Figure 6 The image shows the detection result of the 800-position genotype of the SLC10A1 gene in specimen number 2, which is CT, detected using a qPCR system with the Tag2 sequence added. Detailed Implementation

[0018] To enable those skilled in the art to better understand the technical solutions in this application, the present invention will be further described below with reference to the following embodiments. Obviously, the described embodiments are only some embodiments of this application, and not all embodiments. Based on the embodiments in this application, all other embodiments obtained by those skilled in the art without creative effort should fall within the scope of protection of this application.

[0019] To detect two NTCP deficiency-related mutation sites, c.800C>T and c.263T>C, found in SLC10A1, this invention provides a qPCR kit that utilizes a multiplex PCR mix to amplify the two mutation sites of the target gene and combines primers and probes. This qPCR system contains multiple pairs of complete amplification primers, with each primer pair producing a product containing one target site. For each mutation site, a corresponding (wild-type + mutant) molecular beacon is designed. High Tm value tag sequences can be used to prepare single-stranded PCR products for detecting two gene sites in a single qPCR reaction tube. These single-stranded products hybridize more easily with the molecular beacon probes. This allows for high sensitivity and specificity detection of two mutation sites even with limited DNA template. The primer and molecular beacon probe sequences involved in this invention are shown in Table 1 below.

[0020] Table 1. Primers, molecular beacon probes, and tag sequences in the qPCR system

[0021]

[0022]

[0023] F represents upstream, R represents downstream; W represents wild-type molecular beacon probe, M represents mutant molecular beacon probe; L indicates probe on the negative strand, U indicates probe on the positive strand.

[0024] To obtain sufficient single-stranded PCR products, a Tag sequence (Tag1 primer in the table) with a Tm value > 65℃ was designed; simultaneously, a Tag2 primer with a Tm < 65℃ was designed as a control. When the probe is designed on the positive strand, it binds to the negative strand template, therefore single-stranded amplification should use primer R, and the tag sequence should be added to primer R. When the probe is designed on the negative strand, it binds to the positive strand template, therefore single-stranded amplification should use primer F, and the tag sequence should be added to primer F.

[0025] The Tm values ​​of the primers are within the Tm range of conventional PCR amplification primers, between 50-56℃. The Tm values ​​of the molecular beacon probes are higher, >5℃ higher than the upstream and downstream primers, but lower than the Tm values ​​of the tag sequence. For the first 20 cycles of conventional primer PCR amplification, the annealing temperature is increased to 65℃, at which point only the tag sequence can bind to the template DNA, leading to single-primer amplification, followed by another 25 cycles. Since the same tag sequence is used for single-primer amplification at both sites, single-stranded PCR products from both sites can be prepared simultaneously in one tube, enabling high-sensitivity detection of genotype information for two gene loci in a single step.

[0026] The experimental procedure is as follows:

[0027] 1. PCR amplification:

[0028] Two sets of PCR primers for the two target gene sites were used to perform multiplex PCR amplification in one tube. The total reaction volume was 20 μl, including 2 μl of DNA template at a concentration of 10 ng / μl, 2 μl of 10X PCR reaction buffer (containing Mg2+), 3 μl of 5M Betaine, and 1 μl of enzyme system (including 0.5 μl of 40 mM dNTP mixture, 0.3 μl of 5 U / μl hot-start Taq enzyme, 0.1 μl of 1 U / μl UDG enzyme, and 0.1 μl of 10 mM dUTP). The intermediate concentration of the additional downstream primer in the tube was 0.1 μM, and the final concentration of other primers was 0.25 μM. Deionized water was added to bring the volume to 20 μL.

[0029] The qPCR reaction conditions were: 50℃ for 3 minutes, 95℃ for 10 minutes, 94℃ for 30 seconds, 52℃ for 60 seconds, and 72℃ for 30 seconds for the first 20 cycles; 94℃ for 30 seconds, 65℃ for 60 seconds, and 72℃ for 30 seconds for the last 25 cycles; 72℃ for 5 minutes; and storage at 12℃.

[0030] 2. On-machine testing and result analysis

[0031] The ABI 7500Fast platform was used for real-time amplification detection. Based on the different fluorophores carried by the molecular beacons, the corresponding single-tube multiplex PCR amplification system of this invention was used, along with standard qPCR without tag sequences and qPCR with Tag2 primers containing lower Tm values. DNA (concentration <2 ng / µl) extracted from dried blood smears of 20 newborns was detected. These samples were then sequenced using DNA (concentration >10 ng / µl) extracted from the corresponding newborns' umbilical cord blood for gene locus verification. The detection results are shown in Table 2. As can be seen from Table 2, the sensitivity and specificity of each genotype detection were high. Mutation status of the detected loci is also included.

[0032] Table 2. Experimental data for detecting two mutation sites in the target gene in this invention.

[0033]

[0034]

[0035] Using the genotyping results obtained through sequencing as the gold standard, the accuracy of qPCR without tag sequences for genotyping samples is 14 / 20 = 70%; the accuracy of qPCR with Tag2 sequence primers is 16 / 20 = 80%; and the accuracy of qPCR with Tag1 sequence primers is 20 / 20 = 100%.

[0036] 3. We found that the standard group and Tag2 group were prone to non-specific amplification, leading to errors in genotyping results. For example, in specimen number 6, the genotype at locus 263 was TT; theoretically, only the probe corresponding to the T base should show a reaction signal. However, both the standard group and Tag2 group showed a weak reaction signal at the C base, causing the genotype to be misidentified as TC. Only the probe corresponding to the C base in Tag1 group did not show a reaction signal. See details below. Figure 1-3 .

[0037] Figure 1 In the sample 6, the genotype at position 263 of the SLC10A1 gene is TT. The qPCR system using the Tag1 sequence primers in this invention detected the genotype as TT, which matched the sequencing results. The solid line represents the reaction curve of the T-base probe, and the dashed line represents the reaction curve of the C-base probe. It can be seen that the qPCR of the C-base probe did not produce a peak, indicating a negative reaction.

[0038] Figure 2 In the sample No. 6, the genotype at position 263 of the SLC10A1 gene was TT, but the genotype was detected as TC using a standard qPCR system without the tag sequence, resulting in an incorrect detection result. The solid line represents the reaction curve of the T base probe, and the dashed line represents the reaction curve of the C base probe. It can be seen that the qPCR for the C base probe showed a weak peak, indicating a false positive result for the C base probe, leading to a misclassification of the genotype as TC.

[0039] Figure 3 In the sample 6, the genotype at position 263 of the SLC10A1 gene was TT, but the standard qPCR system with Tag2 sequence primers detected the genotype as TC, resulting in an incorrect detection. The solid line represents the reaction curve of the T-base probe, and the dashed line represents the reaction curve of the C-base probe. It can be seen that the qPCR for the C-base probe showed a weak peak, indicating a false positive result for the C-base probe, leading to the misclassification of the genotype as TC.

[0040] 4. Additionally, it was observed that when testing samples with poor DNA quality, the standard group and Tag2 group sometimes exhibited weak signals from certain probes, leading to negative results and incorrect genotype analysis. For example, in sample number 2, the genotype at locus 800 was CT; theoretically, probes corresponding to both C and T bases should have shown signals. However, in both the standard group and Tag2 group, the C base probe showed a weak response, resulting in a misclassification of the genotype as TT. Only the probe corresponding to the C base in Tag1 group showed a normal signal, detecting the CT genotype. See details below. Figure 4-6 .

[0041] Figure 4 In the sample 2, the genotype at locus 800 of the SLC10A1 gene was CT. The qPCR system using the Tag1 sequence primers used in this invention detected the genotype as CT, consistent with the sequencing results. The solid line represents the reaction curve of the T-base probe, and the dashed line represents the reaction curve of the C-base probe. It can be seen that both the T-base and C-base probes showed peaks in their qPCR reactions.

[0042] Figure 5 In the sample 2, the genotype at locus 800 of the SLC10A1 gene was CT, while the genotype detected by the conventional qPCR system used in this invention was TT. The solid line represents the reaction curve of the T-base probe, and the dashed line represents the reaction curve of the C-base probe. It can be seen that the qPCR reaction of the C-base probe had a very weak peak and was judged as negative by the program.

[0043] Figure 6 In the sample 2, the genotype at locus 800 of the SLC10A1 gene was CT, and the qPCR system using the Tag2 sequence primers detected the genotype as TT. The solid line represents the reaction curve of the T-base probe, and the dashed line represents the reaction curve of the C-base probe. It can be seen that the qPCR reaction peak of the C-base probe was very weak and was judged as negative by the program.

[0044] It should be understood that the disclosed invention is not limited to the specific methods, schemes, and substances described, as these are all subject to variation. It should also be understood that the terminology used herein is for the purpose of describing specific embodiments only and is not intended to limit the scope of the invention, which is limited only by the appended claims.

[0045] Those skilled in the art will also recognize, or be able to identify, many equivalents of the specific embodiments of the invention described herein using no more than conventional experiments. These equivalents are also included in the appended claims.

Claims

1. A qPCR kit for simultaneously detecting two mutation sites on a target gene, characterized in that, The kit includes: Amplify each mutation site using forward and reverse primers; Two Tag sequence primers are used for single-primer amplification of one of the mutation sites, respectively. The Tag sequence primers are formed by adding a Tag sequence to one end of either the forward primer or the reverse primer. The two Tag sequence primers include the same Tag sequence. Single-primer amplification of each mutation site in the two mutation sites uses its own Tag sequence primer. During amplification detection, the PCR products of the two mutation sites are simultaneously prepared into their respective single strands in one tube. Wild-type and mutant molecular beacons for each mutation site; When a molecular beacon probe for a mutation site is designed on the positive strand, the Tag sequence of the mutation site is added to one end of the reverse primer to obtain a Tag sequence primer for that sequence; when a molecular beacon probe for a mutation site is designed on the negative strand, the Tag sequence of the mutation site is added to one end of the forward primer to obtain a Tag sequence primer for that sequence. The Tm values ​​of the forward and reverse primers are between 50 and 56°C, and the Tm value of the Tag sequence primer is not lower than 65°C. The kit is for detecting c.800C>T and c.263T>C at two sites in the SLC10A1 gene; Forward primer SEQ ID NO: 1: CATGGAGACTGGATGC, reverse primer SEQ ID NO: 2: AGAAGAAAAGTGGTCCAA, and tag sequence primer SEQ ID NO: 3: gccatgtcgcgttgctggtgaAGAAGAAAAGTGGTCCAA; wild-type molecular beacon SEQ ID NO: 4: FAM-gtcacCCAACTCTGTTCCACCATCCTCAgtgac-Dabcyl; and mutant molecular beacon SEQ ID NO: 5: VIC-gtcacTCCAACTCTGTTTCACCATCCTCAAgtgac-BHQ1; and The forward primers used for amplifying c.263T>C are SEQ ID NO: 6: GCTCACTTATGGAAGCCTA, the reverse primers are SEQ ID NO: 7: CAGCCACAGACCAAGATG, and the tag sequence primers are SEQ ID NO: 8: gccatgtcgcgttgctggtgaAGAAGAAAAGTGGTCCAA; the wild-type molecular beacon is SEQ ID NO: 9: gccatgtcgcgttgctggtgaGCTCACTTATGGAAGCCTA, and the mutant molecular beacon is SEQ ID NO: 10: Cy5-cgtcacaCCAGTGCCTCAGTGTTCTTCAGCCtgtgacg-BHQ2.

2. A qPCR amplification method for simultaneously detecting two mutation sites on a target gene using the kit described in claim 1 for non-diagnostic purposes.

3. The qPCR amplification method according to claim 2, wherein the method comprises first performing PCR amplification using the forward primer and the reverse primer, and then raising the annealing temperature above the Tm value of the Tag sequence primer, at which point only the Tag sequence primer can bind to the template DNA, thereby causing single primer amplification.

4. The qPCR amplification method according to claim 3, wherein the method uses the qPCR kit according to claim 1, and the qPCR reaction conditions are 50℃ for 3 minutes, 95℃ for 10 minutes, 94℃ for 30 seconds, 52℃ for 60 seconds, and 72℃ for 30 seconds for the first 20 cycles; and 94℃ for 30 seconds, 65℃ for 60 seconds, 72℃ for 30 seconds, and 72℃ for 5 minutes for the next 25 cycles.

Citation Information

Patent Citations

  • PCR fluorescent molecular beacon probe for detecting drug-induced deafness

    CN106957904A

  • Molecular beacon probe, primer pair and detection method for SNPs of GC gene

    CN107227351A

  • Suspension magnetic bead liquid chip kit for detecting multiple mutation sites of SLC10A1 gene

    CN114032299A

  • Asymmetric PCR methods, primers and kits

    US20190153508A1